ABSTRACT
OBJECTIVES: The objective of this survey paper is to present and explain the impact of recent regulations and patient safety initiatives (EU, US and Canada) on Human Factors (HF)/Usability studies and research focusing on Health Information Technology (HIT). METHODS: The authors have selected the most prominent of these recent regulations and initiatives, which rely on validated HF and usability methods and concepts and aim at enhancing the specific process of identification and prevention of technology-induced errors throughout the lifecycle of HIT. RESULTS: The analysis highlights several points of consensus: 1) safety initiatives or regulations applicable to Medical Devices (MD) tend to extend to HIT, 2) Usability is considered a fundamental dimension of HIT safety, 3) HF/Usability methods and the overall Human Centred Design (HCD) approach are considered efficient solutions to ensure the design of safe and usable HIT. However, it appears that MD manufacturers, and a fortiori HIT designers and developers are still far from being able to routinely apply HCD to their products. DISCUSSION AND CONCLUSION: On the research side, we need to analyze manufacturers' difficulties with the application of the HCD process and imposed standards. For each given category of HIT, we need to identify the fundamental usability dimensions and design principles likely to impact patient safety independently of workplace settings or organizations. These should be described in terms of usability flaws, corresponding usage problems experienced by users and related outcomes. This approach requires good quality and well structured reporting of Human Factors / Usability research studies on HIT.
Subject(s)
Medical Informatics , Patient Safety , Canada , HumansABSTRACT
Kinins are neuroactive peptides that could play a role in central autonomic control of blood pressure. Whereas kinin B1R binding sites were increased in specific brain areas of spontaneously hypertensive rats (SHR) and Angiotensin II (AngII)-hypertensive rats, the contribution of kinin B1R in hypertension remains controversial. The aims of the study were to determine: (a) the effects on mean arterial blood pressure (MAP) of centrally and peripherally administered B1R antagonists in SHR (16weeks) and AngII-hypertensive rats (200ng/kg/minx2weeks, s.c.); (b) the contribution of central dopamine in the effects of SSR240612. The rationale is based on the overactivity of the dopaminergic system in hypertension. In both models, SSR240612 (1, 5 and 10mg/kg, gavage) reduced dose-dependently MAP (-75mm Hg at least up to 6-8h) and this therapeutic effect was resolved after 24h. At the dose of 5mg/kg, SSR240612-induced anti-hypertension was prevented by two dopamine receptor blockers, namely raclopride (0.16mg/kg, i.v.) and haloperidol (10mg/kg, s.c.). I.c.v. SSR240612 (1mug) decreased rapidly MAP in both models (1-6h) via a raclopride sensitive mechanism. In comparison, peripherally acting B1R antagonists (R-715 and R-954, 2mg/kg, s.c.) caused shorter and very modest decreases of MAP (from -20 to -30mm Hg). Centrally or peripherally administered B1R antagonists had no effect on MAP in control Wistar-Kyoto rats. Data provide the first pharmacological evidence that the up-regulated brain kinin B1R contributes through a central dopaminergic mechanism (DA-D2R) to the maintenance of arterial hypertension in genetic and experimental animal models of hypertension.
Subject(s)
Bradykinin B1 Receptor Antagonists , Brain/metabolism , Dopamine/metabolism , Hypertension/drug therapy , Hypertension/metabolism , Analysis of Variance , Animals , Blood Pressure/drug effects , Disease Models, Animal , Dopamine Antagonists/pharmacology , Dose-Response Relationship, Drug , Haloperidol/pharmacology , Male , Raclopride/pharmacology , Rats , Rats, Inbred SHR , Rats, Inbred WKY , Receptor, Bradykinin B1/metabolismABSTRACT
Renal fibrosis is the common histological feature of advanced glomerular and tubulointerstitial disease leading to end-stage renal disease (ESRD). However, specific antifibrotic therapies to slow down the evolution to ESRD are still absent. Because persistent inflammation is a key event in the development of fibrosis, we hypothesized that the proinflammatory kinin B1 receptor (B1R) could be such a new target. Here we show that, in the unilateral ureteral obstruction model of renal fibrosis, the B1R is overexpressed and that delayed treatment with an orally active nonpeptide B1R antagonist blocks macrophage infiltration, leading to a reversal of the level of renal fibrosis. In vivo bone marrow transplantation studies as well as in vitro studies on renal cells show that part of this antifibrotic mechanism of B1R blockade involves a direct effect on resident renal cells by inhibiting chemokine CCL2 and CCL7 expression. These findings suggest that blocking the B1R is a promising antifibrotic therapy.
Subject(s)
Bradykinin B1 Receptor Antagonists , Dioxoles/pharmacology , Fibrosis/drug therapy , Inflammation/drug therapy , Kidney Diseases/drug therapy , Sulfonamides/pharmacology , Animals , Chemokine CCL2/metabolism , Chemokine CCL7/metabolism , Connective Tissue Growth Factor/metabolism , Dioxoles/administration & dosage , Drug Administration Schedule , Gene Expression Regulation/drug effects , Gene Expression Regulation/physiology , Humans , Male , Mice , Mice, Knockout , RNA, Messenger/metabolism , Sulfonamides/administration & dosageABSTRACT
The infusion of health care technologies into the home leads to substantial changes in the nature of work for home care nurses and their patients. Nurses and nursing practice must change to capitalize on these innovations. As part of a randomized field experiment evaluating web-based support for home care of patients with chronic heart disease, we engaged nine nurses in a dialogue about their experience integrating this modification of care delivery into their practice. They shared their perceptions of the work they needed to do and their perceptions and expectations for patients and themselves in using technologies to promote and manage self-care. We document three overarching themes that identify preexisting factors that influenced integration or represent the consequences of technology integration into home care: doing tasks differently, making accommodations in the home for devices and computers, and being mindful of existing expectations and skills of both nurses and patients.
Subject(s)
Attitude of Health Personnel , Biotechnology/statistics & numerical data , Home Care Services/statistics & numerical data , Nurses/statistics & numerical data , Nursing Care/statistics & numerical data , Home Care Services/trends , Nursing Care/trends , Surveys and Questionnaires , Systems Integration , Technology Assessment, Biomedical , Wisconsin , WorkloadABSTRACT
BACKGROUND AND PURPOSE: Diabetes causes sensory polyneuropathy with associated pain in the form of tactile allodynia and thermal hyperalgesia which are often intractable and resistant to current therapy. This study tested the beneficial effects of the non-peptide and orally active kinin B(1) receptor antagonist SSR240612 against tactile and cold allodynia in a rat model of insulin resistance. EXPERIMENTAL APPROACH: Rats were fed with 10% D-glucose for 12 weeks and effects of orally administered SSR240612 (0.3-30 mg kg(-1)) were determined on the development of tactile and cold allodynia. Possible interference of SSR240612 with vascular oxidative stress and pancreatic function was also addressed. KEY RESULTS: Glucose-fed rats exhibited tactile and cold allodynia, increases in systolic blood pressure and higher plasma levels of insulin and glucose, at 12 weeks. SSR240612 blocked tactile and cold allodynia at 3 h (ID(50)=5.5 and 7.1 mg kg(-1), respectively) in glucose-fed rats but had no effect in control rats. The antagonist (10 mg kg(-1)) had no effect on plasma glucose and insulin, insulin resistance (HOMA index) and aortic superoxide anion production in glucose-fed rats. CONCLUSIONS AND IMPLICATIONS: We provide the first evidence that the B(1) receptors are involved in allodynia in an experimental rat model of insulin resistance. Allodynia was alleviated by SSR240612 most likely through a direct inhibition of B(1) receptors affecting spinal cord and/or sensory nerve excitation. Thus, orally active non-peptide B(1) receptor antagonists should have clinical therapeutic potential in the treatment of sensory polyneuropathy.
Subject(s)
Analgesics, Non-Narcotic/therapeutic use , Bradykinin B1 Receptor Antagonists , Dioxoles/therapeutic use , Hyperalgesia/drug therapy , Insulin Resistance/physiology , Pain/drug therapy , Sulfonamides/therapeutic use , Animals , Aorta, Thoracic/metabolism , Blood Glucose/analysis , Cold Temperature , Disease Models, Animal , Hot Temperature , Insulin/blood , Male , Oxidative Stress/drug effects , Pain/metabolism , Pain/physiopathology , Rats , Rats, Sprague-Dawley , Superoxides/metabolism , TouchABSTRACT
Models and methods of work system design need to be developed and implemented to advance research in and design for patient safety. In this paper we describe how the Systems Engineering Initiative for Patient Safety (SEIPS) model of work system and patient safety, which provides a framework for understanding the structures, processes and outcomes in health care and their relationships, can be used toward these ends. An application of the SEIPS model in one particular care setting (outpatient surgery) is presented and other practical and research applications of the model are described.
Subject(s)
Ergonomics/standards , Quality Assurance, Health Care , Safety Management/standards , Surgicenters/standards , Humans , Medical Errors/prevention & control , Models, Theoretical , Outcome Assessment, Health Care , Systems Analysis , Task Performance and Analysis , United StatesABSTRACT
Immunocytochemistry (ICC) of thyroid peroxidase (TPO) using the monoclonal antibody MoAb47 has been used as malignancy marker on thyroid fine needle aspiration. However, little is known about the fate of TPO in thyroid carcinoma. We performed a qualitative PCR (Q-PCR) analysis to measure the expression of variants of tpo mRNA in 13 normal tissue samples, 30 benign tumors (BT), 21 follicular carcinomas (FC), 20 classical papillary carcinomas (PCc), 12 follicular variants of papillary carcinomas (PCfv) and nine oncocytic carcinomas (OC). We also studied mutations involving the ras, Braf, ret or pax8 genes. Results of Q-PCR were closely correlated with those of ICC (P < 0.0001; R = 0.59) and showed that overall tpo expression was lower in all carcinomas than in normal and BT (P < 0.05). The ratio tpo2 or tpo3 to tpo1 was inversed in follicular tumors. Genetic mutations were observed in 90% of PCc, 61.9% of FC, 41.7% of PCfv, 0% of OC and 10% in BT. pax8-ppar gamma1 rearrangement was correlated with qualitative changes in tpo mRNA (P < 0.01). These results confirmed the decrease of TPO expression in 97% of thyroid carcinomas regardless of histological type and the overexpression of shorter splice variants in follicular tumors. Both reduction in quantity of TPO and impairment of its maturation process could account for the atypical immunohistochemical reaction of MoAb47 with TPO.
Subject(s)
Carcinoma/enzymology , Gene Expression Regulation, Neoplastic , Genes, Neoplasm/genetics , Iodide Peroxidase/genetics , Thyroid Neoplasms/enzymology , Adult , Aged , Carcinoma/genetics , Down-Regulation , Female , Genes, ras/genetics , Humans , Iodide Peroxidase/analysis , Male , Middle Aged , Mutation , PAX8 Transcription Factor , Paired Box Transcription Factors/genetics , Proto-Oncogene Proteins B-raf/genetics , Proto-Oncogene Proteins c-ret/genetics , RNA, Messenger/analysis , RNA, Messenger/metabolism , Reverse Transcriptase Polymerase Chain Reaction , Thyroid Neoplasms/geneticsABSTRACT
The objective of this study is to understand the viewpoint of healthcare providers with regard to patient safety in outpatient surgery settings. Two methods were used to gather data from the healthcare providers: (1) questionnaire with open-ended questions about six predefined stages of the patient care process; (2) survey with closed questions. With the first method, the main quality and safety of care issues concerned communication to patients, coordination of reports and forms, patient and staff time pressures and standards of care. The first two stages of the outpatient surgery process, i.e. patient work-up prior to day of surgery and patient admission and preparation on the day of surgery, yielded many more comments than the other four stages. The results of the structured questionnaire show that, overall, the healthcare providers report high quality of care provided by themselves (98%) and their surgery centre (96%). With regard to patient safety (i.e. cancellations of surgeries, patient safety problems and serious mistakes), there was a clear difference in perceptions reported by the physicians vs. the nurses and other staff. Nurses and other staff were more likely to report patient safety problems than physicians. The combination of qualitative data from the initial questionnaire and the quantitative data from the structured questionnaire provides a rather complete view of the outpatient surgery staff perceptions of quality and safety of care. This research highlights the importance of getting input from the healthcare providers regarding the quality and safety of care rather than relying only on traditional measures about patient outcomes.
Subject(s)
Ambulatory Surgical Procedures/standards , Attitude of Health Personnel , Quality of Health Care , Safety Management , Surgicenters/standards , Adult , Ergonomics , Female , Health Care Surveys/methods , Humans , Male , Medical Staff, Hospital/psychology , Middle Aged , Models, Organizational , Personnel, Hospital/psychology , Surgicenters/organization & administration , Surveys and Questionnaires , WisconsinABSTRACT
Like children exposed to Chernobyl fallout, the workers who cleaned up after the accident, also known as liquidators, have exhibited an increased incidence of thyroid cancer. A high prevalence of ret/PTC3 rearrangement has been found in pediatric post-Chernobyl thyroid tumors, but this feature has not been investigated in liquidator thyroid tumors. In this study we analyzed the prevalence of ret/PTC1 and ret/PTC3 in thyroid tumors from 21 liquidators, 31 nonirradiated adult Ukrainian patients, and 34 nonirradiated adult French patients. ret rearrangements in carcinomas were found in 83.3% of liquidators, 64.7% of Ukrainian patients, and 42.9% of French patients. The prevalence of ret/PTC1 was statistically similar in the three groups. The prevalence of ret/PTC3 was significantly higher in liquidators than in French patients (P = 0.03) but it was also high in nonirradiated Ukrainian patients who exhibited values intermediate between liquidators and French patients. In adenomas the prevalence of rearrangement was significantly higher in all Ukrainians than in French patients (P = 0.004). Like children exposed to Chernobyl fallout, liquidators showed a high prevalence of ret/PTC3. This finding suggests that irradiation had the same effect regardless of age. However, given the high rate of ret/PTC3 in nonirradiated adult Ukrainians, the possibility of genetic susceptibility or low-level exposure to radiation in that group cannot be excluded.
Subject(s)
Carcinoma, Papillary/etiology , Neoplasms, Radiation-Induced/etiology , Oncogene Proteins/genetics , Radioactive Hazard Release , Thyroid Neoplasms/etiology , Transcription Factors/genetics , Adult , Aged , Carcinoma, Papillary/epidemiology , Child , France/epidemiology , Gene Rearrangement , Humans , Middle Aged , Neoplasms, Radiation-Induced/epidemiology , Nuclear Receptor Coactivators , Oncogene Proteins, Fusion , Protein-Tyrosine Kinases , Thyroid Neoplasms/epidemiology , Ukraine/epidemiologyABSTRACT
The prevalence of H-RAS, K-RAS, and N-RAS gene mutations in thyroid tumors according to malignancy and histology is controversial. Differences in methodology and histological classifications may explain discrepant results. To address this issue, we first performed a pooled analysis of 269 mutations garnered from 39 previous studies. Mutations proved significantly less frequent when detected with direct sequencing than without (12.3% vs. 17%). The rate of mutation involving N-RAS exon 1 (N1) and K-RAS exon 2 (K2) was less than 1%. Mutations of codon 61 of N-RAS (N2) were significantly more frequent in follicular tumors (19%) than in papillary cancers (5%) and significantly more frequent in malignant (25%) than in benign (14%) tumors. H-RAS mutations in codons 12/13 (H1) were found in 2-3% of all types of tumors, but H-RAS mutations in codon 61 (H2) were observed in only 1.4% of tumors, and almost all of them were malignant. K-RAS mutations in exon 1 were found more often in papillary than follicular cancers (2.7% vs. 1.6%) and were sometimes correlated with special epidemiological circumstances. The second part of this study involved analysis of 80 follicular tumors from patients living in Marseille (France) and Kiev (Ukraine). We used direct sequencing after PCR amplification of exons 1 and 2 of the three RAS genes. Common and atypical adenomas were separated using strict cytological criteria. Mutations of H1-RAS were found in 12.5% of common adenomas and one follicular carcinoma (2.9%). Mutations of N2-RAS occurred in 23.3% and 17.6% of atypical adenomas and follicular carcinomas, respectively. These results confirm the predominance of N2-RAS mutations in thyroid follicular tumors and their correlation with malignancy. They support the implication of N2-RAS mutations in the malignant progression of thyroid follicular tumors and the assumption that some atypical adenomas are precursors of follicular carcinomas.
Subject(s)
Adenocarcinoma, Follicular/genetics , Adenoma/genetics , Genes, ras/genetics , Mutation , Thyroid Neoplasms/genetics , Adult , Aged , Female , France , Humans , Male , Middle Aged , UkraineABSTRACT
We report the first mutational study of thymidine kinase 1 (TK1) performed in human solid tumors. We sequenced cDNAs representing the complete coding region of TK1 in human breast (n=22) and colorectal (n=26) cancer. Codon 106 near the ATP binding site constantly differed (ATG --> GTG; Met --> Val) from the one deposited by Bradshaw and Deininger in the Genbank database (Accession number NM_003258). Silent polymorphisms at codon 11 (CCC --> CCT; Pro --> Pro) and codon 75 (GCG --> GCA; Ala --> Ala) were frequently detected in tumors as well as in normal tissues. In breast cancer the two polymorphisms were observed in 63.6% of the samples analyzed. No significant association could be found between polymorphisms and TK activity. In colorectal cancer the incidence of the two changes was 73.1% and 69.2%, respectively. Interestingly, one colon cancer with high cytosolic TK activity displayed two missense mutations located in and near the putative phosphorylation site by tyrosine kinase (s) (TAT --> CAT; Tyr --> His) and by cAMP-, cGMP-dependent protein kinase (TAC --> TGC; Tyr --> Cys), respectively; adjacent normal mucosa showed no mutation. This may open new avenues that imply TK1 activity in tumor cell proliferation.
Subject(s)
Breast Neoplasms/genetics , Colorectal Neoplasms/genetics , DNA Mutational Analysis , Thymidine Kinase/genetics , Adenosine Triphosphate/metabolism , Adult , Aged , Aged, 80 and over , Binding Sites , Cell Line, Tumor , Codon , Cyclic AMP-Dependent Protein Kinases/metabolism , Cyclic GMP-Dependent Protein Kinases/metabolism , Cytosol/metabolism , DNA, Complementary/metabolism , Databases, Genetic , Humans , Middle Aged , Models, Genetic , Molecular Sequence Data , Mutation , Mutation, Missense , Polymorphism, GeneticABSTRACT
SR31747A is a recently described sigma receptor ligand that binds SR31747A-binding protein 1 (SR-BP) and emopamil-binding protein (EBP) (also called the sigma 1 receptor and the human sterol isomerase (HSI), respectively), and has immunoregulatory and antiproliferative activities. To further investigate its antitumour activity and focusing on cancers, which are sensitive to the molecule, we measured the proliferation of different human epithelial breast or prostate cancer cell lines following in vitro and in vivo SR31747A treatment. Firstly, in vitro, we found that nanomolar concentrations of SR31747A dramatically inhibited cell proliferation in both hormono-responsive and -unresponsive cancer cell lines. Secondly, tumour development was significantly decreased in mice treated with SR31747A. In an attempt to decipher the SR31747A mode of action, we found that the two binding sites may not fully account for this activity. Indeed, while competitive experiments indicated that EBP prevails in mediating SR31747A antiproliferative activity, an analysis of the expression of both receptors indicated that the cellular sensitivity to SR31747A is not correlated with either EBP or SR-BP expression. These data suggest that additional binding sites may exist. Preliminary binding studies demonstrated that SR31747A also binds to sigma 2, a protein that has not yet been cloned, but which is considered as a potential marker of the proliferative status of tumour cells. Altogether, our data demonstrate the antitumoural activity of SR31747A both in vitro and in vivo in two different cancer models, broaden the spectrum of its binding proteins and enhance the potential for further therapeutic development of the molecule.
Subject(s)
Antineoplastic Agents/therapeutic use , Cyclohexanes/therapeutic use , Neoplasms, Experimental/drug therapy , Receptors, sigma/metabolism , Animals , Breast Neoplasms/pathology , Cell Division/drug effects , Cells, Cultured , Disease Models, Animal , Humans , Ligands , Male , Mice , Mice, Nude , Neoplasm Transplantation , Prostatic Neoplasms/pathology , Receptors, sigma/drug effects , Tumor Cells, CulturedABSTRACT
OBJECTIVE: In 1999, a first national survey on functional intestinal disorders (FID) revealed the patients' good perception of the medical corps and treatments proposed. The aim of the present study was to assess the physicians' perception of their patients, their symptoms and their degree of satisfaction. METHODS: The survey was conducted among the physicians who had recruited the patients of the initial study. Eight hundred and eighty five replies were analysed (general practitioners--GPs: 88%; gastro-enterologists--GE: 11%). RESULTS: The mean number of patients with FID seen in one week was of 11.40 (GP: 10.80; GE: 16.29). Thirty percent of patients were seen for the first time by a GP and 65 percent by a GE. The mean yearly number of consultations for these patients was of 7.16 for the GPs and 3.81 pour les GEs. A coloscopy was prescribed by 49% of GPs and 66% of GEs. The pain and transit disorders mentioned in 98 and 78.7% of cases had evolved over a mean of 56.57 months. COMMENTS: Although aware of the repercussion of FID in daily life, the practitioners evaluated a psychological component of 69% in the expression of the disorder. They considered the pain intense in 6% of cases versus the 41% expressed by the patient. The scores out of 10 for 8 items showed a mean result of 6.86 in their evaluation of the degree of the patients' understanding of their disease and its treatment, and of 6.13 for the quality of the medical act. These same criteria, assessed one year earlier by the patients themselves, showed better scores.
Subject(s)
Attitude of Health Personnel , Intestinal Diseases/complications , Adult , Aged , Family Practice , Female , Gastroenterology , Health Surveys , Humans , Intestinal Diseases/psychology , Male , Middle Aged , Pain , Patient Satisfaction , Physician-Patient Relations , Quality of Life , Stress, PsychologicalABSTRACT
The peripheral benzodiazepine receptor (PBR) has been implicated in growth control of various tumour models. Although colorectal cancers were found to overexpress PBR, the functional role of PBR in colorectal cancer growth has not been addressed to date. Using primary cell cultures of human colorectal cancers and the human colorectal carcinoma cell lines HT29, LS174T, and Colo320 DM we studied the involvement of PBR in the growth control and apoptosis of colorectal cancers. Both mRNA and protein expression of PBR were detected by RT-PCR and flow cytometry. Using confocal laser scanning microscopy and immunohistochemistry the PBR was localized in the mitochondria. The specific PBR ligands FGIN-1-27, PK 11195, or Ro5-4864 inhibited cell proliferation dose-dependently. FGIN-1-27 decreased the mitochondrial membrane potential, which indicates an early event in apoptosis. Furthermore, FGIN-1-27, PK 11195 or Ro5-4864 increased caspase-3 activity. In addition to their apoptosis-inducing effects, PBR ligands induced cell cycle arrest in the G(1)/G(0)-phase. Thus, our data demonstrate a functional involvement of PBR in colorectal cancer growth and qualify the PBR as a possible target for innovative therapeutic approaches in colorectal cancer.
Subject(s)
Apoptosis/drug effects , Cell Cycle/drug effects , Colorectal Neoplasms/pathology , Ligands , Receptors, GABA-A/genetics , Adult , Aged , Benzodiazepinones/metabolism , Benzodiazepinones/pharmacology , Cell Cycle/physiology , Colorectal Neoplasms/genetics , Colorectal Neoplasms/physiopathology , Dose-Response Relationship, Drug , G1 Phase/drug effects , G1 Phase/physiology , Gene Expression Regulation, Neoplastic , HT29 Cells , Humans , Indoleacetic Acids/metabolism , Indoleacetic Acids/pharmacology , Intracellular Membranes/drug effects , Intracellular Membranes/physiology , Isoquinolines/metabolism , Isoquinolines/pharmacology , Membrane Potentials/drug effects , Middle Aged , Mitochondria/chemistry , Mitochondria/drug effects , Mitochondria/physiology , RNA, Messenger/genetics , RNA, Messenger/metabolism , Receptors, GABA-A/metabolism , Resting Phase, Cell Cycle/drug effects , Resting Phase, Cell Cycle/physiology , Tumor Cells, Cultured/drug effectsABSTRACT
We recently reported that, during in vitro thyroid-hormone synthesis, H(2)O(2) stress cleaved thyroglobulin (Tg) into C-terminal peptides. These peptides were found to contain the immunodominant region of Tg recognized by Tg autoantibodies from patients with an autoimmune thyroid disease. To test the hypothesis that Tg fragmentation is an early upstream initiating event involved in Tg autoimmune response and the consequence of oxidative injuries, we studied the effect of H(2)O(2) stress on human thyroid cells. In culture conditions allowing Tg synthesis and iodine organification by the cells, we found that bolus addition of increasing millimolar doses of H(2)O(2) induced a dose-response appearance of floating cells in the culture medium. These cells apparently resulted from a necrotic process, and they bore iodinated Tg fragments. These fragments were found to be similar to those previously obtained in vitro from purified Tg. In both cases, Tg peptides were recognized by a well-defined monoclonal antibody directed to the immunodominant region of Tg. The smallest immunoreactive Tg peptide had a molecular mass of 40 kDa and entered human thyrocytes more efficiently than the entire Tg. These data suggest that thyrocytes exposed to locally increased H(2)O(2) doses accumulate fragmented Tg for further delivery into surrounding living thyrocytes in the course of an autoimmune response.
Subject(s)
Hydrogen Peroxide/pharmacology , Peptide Fragments/metabolism , Thyroglobulin/metabolism , Thyroid Gland/metabolism , Thyroiditis, Autoimmune/immunology , Adenoma/surgery , Adult , Cell Death/drug effects , Cells, Cultured , Humans , Immunoglobulins, Thyroid-Stimulating/immunology , Middle Aged , Oxidation-Reduction , Peptide Fragments/immunology , Protein Binding , Thyroid Gland/drug effects , Thyroid Neoplasms/surgeryABSTRACT
We report on the case of a 35 year-old woman who was initially admitted for acute pancreatitis in october 1995. The patient was suffering from asthma (since childhood) and diffuse abdominal pain (since adolescence). The diagnosis of cystic fibrosis was made fortuitously during a sterility evaluation. After extensive etiological screening the acute pancreatitis was considered to be a manifestation of the cystic fibrosis. Despite therapy with pancreatic enzymes, the patient continued to suffer from chronic abdominal pain. High intake of analgesics was required. Until December 1995, the patient was repeatedly admitted for episodes of acute pancreatitis. In January 1996, we initiated a preventive treatment with subcutaneous octreotide between 100 and 200 microgram, three time a day. Thereafter, there were fewer episodes of pancreatitis and the consumption of analgesics decreased. Side effects of octreotide were intermittent diarrhea and development of cholelithiasis that was complicated by biliary migration in November 1998. In June 1999, the prolonged-release form of the molecule was given without modification of the efficacy.
Subject(s)
Cystic Fibrosis/complications , Cystic Fibrosis/diagnosis , Gastrointestinal Agents/therapeutic use , Octreotide/therapeutic use , Pancreatitis/etiology , Pancreatitis/prevention & control , Acute Disease , Adult , Female , Gastrointestinal Agents/adverse effects , Humans , Octreotide/adverse effects , RecurrenceABSTRACT
The peripheral benzodiazepine receptor (PBR) is a mitochondrial protein involved in the formation of mitochondrial permeability transition (PT) pores which play a critical role during the early events of apoptosis. PBRs are located in many tissues and are strongly expressed in the superficial layers of human epidermis. PBRs play a protective role against free radical damage and PBR ligands modulate apoptosis. To investigate the role of PBR during the early events of ultraviolet (UV)-mediated apoptosis we compared the effects of UVB on PBR-transfected Jurkat cells and their wild type counterparts devoid of any PBR expression. Results indicate that early after UVB exposure (up to 4 h), PBR-transfected cells were more resistant to apoptosis and exhibited a delayed mitochondrial transmembrane potential drop, a diminished superoxide anions production, and a reduced caspase-3 activation. Taken together these findings suggest that PBR may regulate early death signals leading to UV induced apoptosis.
Subject(s)
Apoptosis/radiation effects , Receptors, GABA-A/metabolism , Ultraviolet Rays , Caspase 3 , Caspases/metabolism , Enzyme Activation/radiation effects , Humans , Intracellular Membranes/metabolism , Intracellular Membranes/radiation effects , Jurkat Cells , Membrane Potentials/radiation effects , Mitochondria/metabolism , Mitochondria/radiation effects , Permeability/radiation effects , Receptors, GABA-A/genetics , Superoxides/metabolism , TransfectionABSTRACT
OBJECTIVE: An anonymous self-administered questionnaire was completed by patients with gastrointestinal functional disorders to determine symptoms and management strategies employed. METHODS: The questionnaire was filled out by 1266 patients who complained of abdominal pain in 8 out of 10 cases as well as disturbed bowel movements and abdominal distension. RESULTS: Half of the patients had started self medication, generally before consulting their general practitioner. The patients were generally satisfied with their medical care. Superior efficacy was observed for antispasmodics in combination or not with anxiolytic agents (75%, 71% and 69% efficacy respectively). The digestive disorders led to an interruption of occupational activities in 21% of the patients. DISCUSSION: Optimal management of patients with this benign chronic disorder that nevertheless has a major impact on their quality of life requires sufficient knowledge of the opinions of both the patients and their physicians. A second survey on this question has been initiated.